Tecrea Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tecrea Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11292
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tecrea Ltd (Tecrea) is a cell and tissue delivery technology for research and drug development applications. The company develops Nanocin reagents and ingredients support research and development in academic and industrial research labs. It develops Nanocin-plasmid and Nanocin-RNA kits that empower transfection of nucleic acids into a wide range of cell types. Tecrea also develops Nanocin-PRO kits that delivers proteins and peptides; Nanocin-SM kits that enable effective delivery of small molecules. The company partners with government, academic and industrial partners to study nanoparticle formation and cell and tissue delivery mechanisms. Tecrea is headquartered in London, the UK.

Tecrea Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecrea Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tecrea Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Toleranzia Enters into Agreement with Tecrea 10
Enzo Life Sciences Enters into Distribution Agreement with Tecrea 11
Sanbio Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 12
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 13
Licensing Agreements 14
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 14
Tecrea Ltd – Key Competitors 15
Tecrea Ltd – Key Employees 16
Tecrea Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Tecrea Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecrea Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecrea Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Toleranzia Enters into Agreement with Tecrea 10
Enzo Life Sciences Enters into Distribution Agreement with Tecrea 11
Sanbio Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 12
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 13
Tecrea Enters into Licensing Agreement with Blueberry Therapeutics for Nanocin 14
Tecrea Ltd, Key Competitors 15
Tecrea Ltd, Key Employees 16

List of Figures
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecrea Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tecrea Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Calytrix Technologies Pty Ltd.:企業の戦略・SWOT・財務情報
    Calytrix Technologies Pty Ltd. - Strategy, SWOT and Corporate Finance Report Summary Calytrix Technologies Pty Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sygnature Discovery Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sygnature Discovery Ltd (Sygnature) is a drug discovery company that offers medicinal chemistry, bioscience, computational chemistry, and fragment-based drug discovery programs. The company offers services for various phases of drug discovery which include hit identification, hit to lead, an …
  • Florida Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Florida Hospital is a healthcare service provider. The hospital offers clinical services and treatments in the areas of bariatric, behavioral health, cancer, cardiovascular, diabetes, emergency services, gastrointestinal, general surgery, gynecology, hepatology, imaging, laboratory services, …
  • Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析
    Summary Microbix Biosystems Inc (Microbix) is a provider of biological and technology solutions for human health and wellbeing. The company's products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. M …
  • Berkshire Hathaway Energy Co:企業の戦略的SWOT分析
    Berkshire Hathaway Energy Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • ViraTherapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ViraTherapeutics GmbH (ViraTherapeutics) is a biotechnology company that develops high potential anti-cancer therapeutics based on cancer-destroying oncolytic viruses. The company provides VSV-GP which is a proprietary oncolytic virus platform, which helps in destroying cancer cells and is u …
  • Datang International Power Generation Co Ltd (991):企業の財務・戦略的SWOT分析
    Datang International Power Generation Co Ltd (991) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Nielsen Holdings plc (NLSN):企業の財務・戦略的SWOT分析
    Nielsen Holdings plc (NLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Mankind Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mankind Pharma Ltd (MPL) is a manufacturer and supplier of prescriptions medicines, over-the-counter and FMCG products. The company offers prescription medicines in dosage forms of oral solids, oral liquids, soft gelatine capsules and injectables. Its products are used in therapeutic areas o …
  • Bio-Rad Laboratories Inc (BIO):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics …
  • Etihad Aviation Group PJSC:企業の戦略・SWOT・財務情報
    Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report Summary Etihad Aviation Group PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • XState Resources Ltd (XST):企業の財務・戦略的SWOT分析
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mologic Ltd-医療機器分野:企業M&A・提携分析
    Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and markets in vitro diagnostic medical devices. The company’s products include bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit. Its experti …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company offers monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed fo …
  • Kancera AB (KAN):企業の財務・戦略的SWOT分析
    Summary Kancera AB (Kancera) is a developer of drug candidates for the treatment of cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, used to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping …
  • Northwest Bancshares Inc:企業の戦略・SWOT・財務情報
    Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report Summary Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆